Hepatitis Weekly articles from April 2009

Hepatitis Weekly archives from April 2009

2-day results predict ultimate response to therapy in chronic hepatitis C.
April 6, 2009... A new study suggests that previously noted low rates of successful hepatitis C virus (HCV) therapy in African Americans are in large part due to very early differences in the antiviral activity induced by interferon. The study is published in...

Study results from Showa University, Medical Department provide new insights into acute hepatitis.
April 6, 2009... According to a study from Tokyo, Japan, "We investigated the relationship between the magnitude of comprehensive hepatitis C virus (HCV)-specific CD8(+) T-cell responses and the clinical course of acute HCV infection. Six consecutive patients...

Researchers at Baylor College of Medicine, College of Medicine have published new data on autoimmune hemolytic anemia.
April 6, 2009... According to recent research from the United States, "There is emerging evidence that hepatitis C virus (HCV) infection play a role in the etiology of immune thrombocytopenia purpura (ITP) and autoimmune hemolytic anemia (AIHA), both of which...

Research from R. Sauni and colleagues has provided new data on hepatitis A virus.
April 6, 2009... "Officially 10-26 cases of vibration-induced white fingers (VWF) have been reported annually in Finland. It has been suggested that the numbers are underestimated," scientists in Tampere, Finland report (see also Hepatitis A Virus). "The...

Study findings from University of Navarra provide new insights into hepatitis B virus.
April 6, 2009... According to recent research published in the Journal of Interferon and Cytokine Research, "Interferon alpha (IFN alpha) is the first line treatment for chronic hepatitis B and C. In order to test new IFN alpha delivery systems and investigate...

New hepatitis C virus findings from S.S. Mansy and co-researchers published.(Report)
April 6, 2009... "The present work highlights intracellular viral morphogenesis and virus-host cell interactions in patients proved to be infected with HCV. The material of this study consisted of 28 liver biopsies taken from patients positive for serum HCV-RNA...

New hepatitis C virus study results from A.V. Ivanov et al described.
April 6, 2009... According to recent research from Russia, "Hepatitis C virus (HCV) NS5A phosphoprotein is a component of virus replicase. Here we demonstrate that in vitro unphosphorylated NS5A protein inhibits HCV RNA-dependent RNA polymerase (RdRp) activity...

New hepatitis C virus study results reported from A.A. Thompson et al.
April 6, 2009... According to recent research published in the journal Biochemistry, "While nonstructural protein 4B (NS4B) from hepatitis C virus (HCV) is absolutely required for viral propagation, a full understanding of the enzymatic properties of this...

Reports summarize hepatitis C virus study results from E. Barnes and co-researchers.
April 6, 2009... According to recent research from Oxford, the United Kingdom, "The effect that high-dose interferon (IFN)-alpha induction therapy for hepatitis C virus (HCV) infection has on cellular immune responses is currently unknown. Thirty-one...

Research conducted at University of California has provided new information about hepatitis C virus.
April 6, 2009... According to recent research from the United States, "Alcohol synergistically enhances the progression of liver disease and the risk for liver cancer caused by hepatitis C virus (HCV). However, the molecular mechanism of this synergy remains...

Saga University, Medical Department publishes research in hepatitis C virus.
April 6, 2009... According to a study from Saga, Japan, "Thirteen years ago, a 65-year-old woman was diagnosed to have chronic active hepatitis with hepatitis C virus. After starting interferon alpha administration, she noticed edema and hypoalbuminemia." ...

Studies from S.W. Shao and colleagues reveal new findings on hepatitis C virus.
April 6, 2009... "To observe the influence of HCV F protein on apoptosis of HepG2 cells, and explore the association between F protein and NF-kappa B signal pathway. HCV 1b F gene containing HepG2-F cells and HCV 1b C gene containing HepG2-C cells were treated...

Findings in hepatitis E virus reported from K. Yamada and co-researchers.(Report)
April 6, 2009... According to a study from Tochigi, Japan, "A full-length infectious cDNA clone (pJE03-1760F/wt) of a genotype 3 hepatitis E virus (HEV) (strain JE03-1760F) obtained from a faecal specimen was constructed ill this study. Upon transfection of the...

Study data from F. Fong and co-authors update knowledge of hepatitis E virus.
April 6, 2009... According to a study from the United Kingdom, "Neuralgic amyrotrophy (NA) is characterised by neuropathic pain and patchy paresis of the upper or lower limbs, usually involving the upper and middle trunks of the brachial plexus. The aetiology...

New findings in hepatocellular cancer described from University of Minnesota.
April 6, 2009... "Chronic infection with the hepatitis B virus (HBV) is the most important risk factor for hepatocellular carcinoma (HCC). However, determinants of HCC risk in infected individuals are not well understood," scientists writing in the journal...

New life sciences study findings recently were reported by A. Pacheco and co-researchers.
April 6, 2009... "In eukaryotic cells translation initiation occurs through two alternative mechanisms, a cap-dependent operating in the majority of mRNAs, and a 5-end-independent driven by internal ribosome entry site (IRES) elements, specific for a subset of...

New proteomics findings from J.Y.H. Chan and co-authors described.(Report)
April 6, 2009... According to a study from Taipei, Taiwan, "The mechanism underlying the protein-protein interaction of hnRNP K and PRMT family proteins is unclear. We examined and confirmed the arginine methylation of hnRNP K protein by PRMT1, not CARM1, via...

Data from Wuhan University, Center for Gene Diagnosis provide new insights into hepatitis B virus genetics.(Report)
April 6, 2009... New research, 'Polymorphisms and plasma soluble levels of E-selectin in patients with chronic hepatitis B virus infection,' is the subject of a report. "Infections with hepatitis B virus (HBV) may lead to a distinct clinical outcome which is...

Investigators at Ludwig-Maximilians University publish new data on neuropsychiatry therapy.
April 6, 2009... Fresh data on neuropsychiatry are presented in the report 'Neuropsychiatric disorders related to interferon and interleukins treatment.' According to a study from Munich, Germany, "Certain cytokines such as interferon-alpha and interleukin-2...

New cytomegalovirus study findings reported from University of California.(Report)
April 6, 2009... "Cucumber Mosaic Virus (CMV) is a plant infecting tripartite positive-strand RNA virus. In addition to three genomic and two known subgenomic RNAs, CMV strains of subgroup II (e.g," scientists in the United States report (see also Hepatitis)....

Research on hepatitis detailed by scientists at Okayama University.
April 6, 2009... According to recent research published in the journal Hepatology Research, "Antinuclear antibodies (ANA) are the main serologic markers of type 1 autoimmune hepatitis (AIH); however 20-30% of patients are negative for ANA. We assessed the...

Researchers from University of Saskatchewan report recent findings in hepatolenticular degeneration.
April 6, 2009... "Wilson's disease is a human genetic disorder which results in copper accumulation in liver and brain. Treatments such as copper chelation therapy or dietary supplementation with zinc can ameliorate the effects of the disease, but if left...

Research data from University of California update understanding of stem cell research.(Report)
April 6, 2009... "The neurotropic JHM strain of mouse hepatitis virus (JHMV) replicates primarily within glial cells following intracranial inoculation of susceptible mice, with relative sparing of neurons. This study demonstrates that glial cells derived from...

Anadys Pharmaceuticals to Present at Future Leaders in the Biotech Industry.
April 6, 2009... Anadys Pharmaceuticals, Inc. (NASDAQ:ANDS) announced that it will present at the Future Leaders in the Biotech Industry conference on Thursday, April 2, 2009 at 2:00 p.m. EDT (11:00 a.m. PDT). The conference is being held at the Millennium...

Celsion Receives Orphan Drug Designation for ThermoDox[R] to Treat Primary Liver Cancer.
April 6, 2009... Celsion Corporation (NASDAQ:CLSN), a leading oncology drug development company, announced that the U.S. Food and Drug Administration (FDA ) has granted orphan drug designation for its lead compound, ThermoDox®, a proprietary heat-activated...

HARD TO TREAT DISEASES HTDS Granted Registration and Licensing Approval By Vietnam FDA.
April 6, 2009... Hard to Treat Diseases (HTDS) www.htdsmedical.com today after the market closed announced that Mellow Hope a subsidiary of HTDS was granted Registration And Licensing Approval By Vietnam Food and Drug Administration (FDA) (see also Hard to...

Aethlon Medical Announces Data Supported Strategy to Increase Hepatitis-C (HCV) Cure Rates.
April 6, 2009... Aethlon Medical, Inc. (OTC Bulletin Board: AEMD) announced clinical data that supports the advancement of the Aethlon Hemopurifier(R) as an adjunct therapy to increase Hepatitis-C (HCV) cure rates. The Hemopurifier(R) is a first-in-class...

Anadys Pharmaceuticals to Present at the Citi Biotech Day.
April 6, 2009... Anadys Pharmaceuticals, Inc. (NASDAQ:ANDS) announced that it will present at Citi's 4th Annual Biotech Day on Wednesday, April 1, 2009 at 11:20 a.m. EDT (8:20 a.m. PDT). The conference will be held at the 388 Greenwich Street Conference Center...

Disease and Therapy Review: Hepatitis B - Available Now.
April 6, 2009... Research and Markets (http://www.researchandmarkets.com/research/816bc7/disease_and_therap) has announced the addition of the "Disease and Therapy Review: Hepatitis B" report to their offering (see also Research and Markets). The...

Mutations within a conservative region of HCV affects the therapy.
April 13, 2009... At least 200 million individuals are currently infected with hepatitis C virus (HCV) worldwide. Approximately 30%-50% of patients respond to interferon/ribavirin combination therapy. Response to interferon therapy depends mainly on viral and...

Research from Emory University in the area of cytokines published.
April 13, 2009... "Interferon (IFN)-alpha has been used to study the effects of innate immune cytokines on the brain and behavior in humans. The degree to which peripheral administration of IFN-alpha accesses the brain and is associated with a central nervous...

Research data from C.L. Netherton and colleagues update understanding of DNA research.
April 13, 2009... "Increasing evidence points to the importance of the interferon (IFN) response in determining the host range and virulence of African swine fever virus (ASFV). Infection with attenuated strains of ASFV leads to the upregulation of genes...

Research from Fukui University yields new data on encephalomyelitis.
April 13, 2009... According to recent research from Fukui, Japan, "We describe the case of a 36-year-old woman who developed acute encephalo-myelitis after acute viral hepatitis type B. She was admitted to the hospital with a history of general malaise and...

Research on fibrosis described by scientists at St. Louis University.
April 13, 2009... According to recent research published in the journal Hepatology, "One hundred fifty patients with sustained virologic response (SVR) after treatment of chronic hepatitis C were enrolled in a long-term clinical follow-up study; patients were...

Reports outline graft-versus-host disease research from S.B. Harvey and colleagues.
April 13, 2009... "The glyco-isoforms of intact apolipoprotein C3 (ApoC3) were used to probe glycomic changes associated with obesity and recovery following bariatric surgery, liver diseases such as chronic hepatitis C (CHC) and alcoholic liver cirrhosis, as...

Studies from Niigata University yield new data on hepatic failure.
April 13, 2009... According to recent research from Niigata, Japan, "Auxiliary partial orthotopic liver transplantation (APOLT) or heterotopic auxiliary partial liver transplantation (HAPLT) was initially indicated for potentially reversible fulminant hepatic...

Study data from X. Kui and colleagues update understanding of hepatitis.(Report)
April 13, 2009... "Virus-like particles (VLPs) are highly immunogenic. In this study, gene fragments encoding hepatitis A virus (HAV) vp1 (aa 24-171), a hepatitis E virus (HEV) ORF2 gene fragment encoding aa 431-615, and gene fragments encoding a nine-peptide...

Findings from K. Liu and co-authors provide new insights into hepatitis B virus.(Report)
April 13, 2009... "Hepatitis B virus (HBV) infection is a major health concern with more than two billion individuals currently infected worldwide. Despite the prevalence of infection, gaining a complete understanding of the molecular mechanisms of HBV infection...

Findings from Yonsei University, Medical Department provide new insights into hepatitis B virus.
April 13, 2009... In this recently published article, scientists in Seoul, South Korea conducted a study "To investigate the performance of liver stiffness measurement (LSM) in combination with available noninvasive markers in hepatitis B virus-related chronic...

New hepatitis B virus findings from University of Tehran described.
April 13, 2009... "A nanoparticle-based electrochemical method for detection of hepatitis B virus DNA sequences has been developed," investigators in Iran report (see also Hepatitis B Virus). "This method relies on the adsorption of amplified hepatitis B...

New hepatitis B virus study findings recently were published by N. Trehanpati and co-researchers.
April 13, 2009... "CD4+ T and regulatory T cells (Tregs) seem to play a key role in persistence of hepatitis B virus (HBV) infection. However, the molecular events by which Tregs exert their modulatory activity are largely unknown," investigators in New Delhi,...

Research from G.L.H. Wong et al broadens understanding of hepatitis B virus.
April 13, 2009... "We analyzed. the clinical factors associated with advanced liver fibrosis in hepatitis B e antigen (HBeAg)-positive chronic hepatitis B patients. We prospectively recruited treatment-naive HBeAg-positive patients for liver stiffness...

Scientists at Sichuan University publish research in hepatitis B virus.
April 13, 2009... "The hepatitis B virus-encoded X (HBx) protein coactivates transcription of a variety of viral and cellular genes and it is believed to play essential roles in viral replication and hepatocarcinogenesis. To examine the pleiotropic effects of...

Studies from G. Squintani et al in the area of hepatitis B virus described.
April 13, 2009... According to recent research from Verona, Italy, "We report on the first association of celiac disease, polyarteritis nodosa and HBV infection in a patient who developed a neuropathy. On admission his general and neurological conditions were...

Studies from Shandong University further understanding of hepatitis B virus.(Report)
April 13, 2009... According to a study from Jinan, People's Republic of China, " Hepatitis B virus (HBV) x protein (HBx) in HepG2 cells causes a moderate decrease in proteolysis activity of the proteasome. A highly conserved Kunitz-type serine protease inhibitor...

Data from J. Cox and colleagues advance knowledge in hepatitis C virus.
April 13, 2009... According to a study from Montreal, Canada, "Awareness of hepatitis C virus (HCV) infection status is expected to influence risk behaviors. In 2004-2005, injection drug users (IDUs) recruited from syringe exchange programs (SEPs) and methadone...

Data on hepatitis C virus described by Y. Arase et al.
April 13, 2009... According to recent research from Toranomon, Japan, "Diabetes is present in patients with chronic hepatitis C virus infection. The aim of this retrospective cohort study was to assess the cumulative development incidence and predictive factors...

Investigators at Auburn University release new data on hepatitis C virus.
April 13, 2009... "The case of a patient with hepatitis C who developed elevated hepatic transaminase levels associated with the use of interferon alfacon-1 and ribavirin is described. A 55-year-old Caucasian man arrived at a hepatitis C clinic to discuss...

New findings from R. Suzuki and co-authors in the area of hepatitis C virus published.(Report)
April 13, 2009... According to a study from Toyama, Japan, "We have previously reported on the ubiquitylation and degradation of hepatitis C virus core protein. Here we demonstrate that proteasomal degradation of the core protein is mediated by two distinct...

New findings reported from D.M. Jones and co-authors describe advances in hepatitis C virus.(Report)
April 13, 2009... "Studies of the hepatitis C virus (HCV) life cycle have been aided by development of in vitro systems that enable replication of viral RNA and production of infectious virus. However, the functions of the individual proteins, especially those...

New hepatitis C virus data have been reported by Z.M. Younossi and co-authors.
April 13, 2009... "Responsiveness to hepatitis C virus (HCV) therapy depends on viral and host factors. Our aim was to assess sustained virologic response (SVR)-associated early gene expression in patients with HCV receiving pegylated interferon-alpha2a...

New hepatitis C virus study findings have been reported from F. Velazquez et al.
April 13, 2009... "HCV infection is considered a silent epidemic because most people infected do not develop acute symptoms. Instead, the disease progresses to a chronic state leading to cirrhosis and hepatocarcinoma," researchers in the United States report...

New hepatitis C virus study findings recently were published by R. Crabbe and co-researchers.
April 13, 2009... According to recent research from Lausanne, Switzerland, "Debio 025 is a cyclophilin (Cyp) inhibitor without calcineurin-binding properties. The drug inhibits viral replication of genotype 1b and 2a replicons in nanomolar concentrations and...

New hepatitis C virus study findings reported from University of Florida.
April 13, 2009... According to recent research from the United States, "Pegylated interferon alfa-2a/2b is used in combination with ribavirin to treat patients with chronic hepatitis C (CHC), although many do not achieve a sustained virologic response (SVR)....

Recent findings in hepatitis C virus described by J.F. Rossignol and colleagues.
April 13, 2009... "Sustained virologic response (SVR) rates of 50%-60% have been achieved in patients with chronic hepatitis C genotype 4 treated with peginterferon plus ribavirin. The safety and efficacy of nitazoxanide plus peginterferon alfa-2a, with or...

Research from Showa University broadens understanding of hepatitis C virus.
April 13, 2009... "Hepatitis C virus (HCV) infection is a major burden after liver transplantation. There is no effective treatment for these patients, therefore management is challenging," researchers in Yokohama, Japan report (see also Hepatitis C Virus). ...

Research from University of Bonn reveals new findings on hepatitis C virus.(Report)
April 13, 2009... According to a study from Bonn, Germany, " Detection and quantification of hepatitis C virus (HCV) RNA is integral to diagnostic and therapeutic regimens. All molecular assays target the viral 5'-noncoding region (59-NCR), and all show...

Research from University of Pennsylvania, Medical Department in hepatitis C virus provides new insights.
April 13, 2009... "CD56(+) T cells are abundant in liver and play an important role in defense against viral infections. However, the role of CD56(+) T cells in control of hepatitis C virus (HCV) infection remains to be determined," scientists in the United...

Researchers at University of Alberta have published new data on hepatitis C virus.
April 13, 2009... According to recent research from Edmonton, Canada, "Anti-hepatitis C virus (HCV) drug development has been challenged by a lack of experience with inhibitors inclusive of in vitro, animal model, and clinical study. This manuscript outlines...

Studies conducted at P. Liu et al on hepatitis C virus recently published.(Report)
April 13, 2009... According to recent research from Shenyang, People's Republic of China, " The aim of this study was to investigate the relationships between serum hepatitis C virus (HCV)-RNA titer, alanine transaminase (ALT) level, and the degree of liver...

University of Michigan details research in hepatitis C virus.
April 13, 2009... "Serum fibrosis marker levels during the lead-in treatment phase of patients enrolled in the Hepatitis C Antiviral Long-term Treatment against Cirrhosis (HALT-C) trial were determined. Week 0, 24, 48, and 72 serum samples were analyzed for...

Findings in hepatitis E virus reported from Fudan University.(Report)
April 13, 2009... According to a study from Shanghai, People's Republic of China, "Hepatitis E has been hypothesized as a zoonosis." "However, there is no definite conclusion about which animal species contribute to hepatitis E virus (HEV) infection in...

Reports from S.A. Rutjes et al highlight recent research in hepatitis E virus.
April 13, 2009... According to recent research from Netherlands, "Non-travel-related hepatitis E virus (HEV) genotype 3 infections in persons in the Netherlands may have a zoonotic, foodborne, or water-borne origin. Possible reservoirs for HEV transmission by...

Studies from Mamunalmahtab et al have provided new data on hepatitis E virus.
April 13, 2009... "Acute hepatitis is seen sporadically round the year in Bangladesh. The incidence of acute viral hepatitis E increases after floods as this allows sewerage contamination of piped and groundwater," scientists in Dhaka, Bangladesh report (see...

Research results from Chonnam National University update understanding of hepatocellular cancer.
April 13, 2009... According to recent research from South Korea, "Dermatomyositis (DM) is an idiopathic inflammatory myopathy (IIM) with typical cutaneous manifestations. It has been proposed that DM may be caused by autoimmune responses to viral infections, and...

Researchers at Henry Ford Hospital publish new data on hepatocellular cancer.
April 13, 2009... "We combined data from two liver transplant centers to determine the tumor characteristics and outcomes of 51 patients transplanted with incidental hepatocellular carcinoma (iHCC) compared with 143 patients transplanted for previously known HCC...

New interferon research from Western Psychiatric Institute outlined.
April 13, 2009... According to recent research from the United States, "Major depressive disorder (MDD) occurs in a subset of patients receiving interferon-alpha treatment, although many are resilient to this side effect. Genetic differences in the serotonin...

Researchers from Cancer Research Center report recent findings in cancer.
April 13, 2009... New investigation results, 'The dynamic DNA methylomes of double-stranded DNA viruses associated with human cancer,' are detailed in a study published in Genome Research. According to recent research from Madrid, Spain, "The natural history of...

Recent findings in coagulation risk factors described by researchers from University Medical Center, Department of Haematology.(Clinical report)
April 13, 2009... Data detailed in 'Occurrence, course and risk factors of depression during antiviral treatment for chronic hepatitis C in patients with inherited bleeding disorders: a prospective study' have been presented. "Treatment of hepatitis C virus...

Reports from Hospital for Sick Children add new data to research in coagulation vaccines.
April 13, 2009... Current study results from the report, 'Hepatitis A and B immunization for individuals with inherited bleeding disorders,' have been published. According to recent research from Toronto, Canada, "Hepatitis A and B vaccines are highly effective...

Findings in hepatitis A virus vaccines reported from D. Schmid and co-researchers.
April 13, 2009... Researchers detail in 'Foodborne outbreak of hepatitis A, November 2007-January 2008, Austria,' new data in hepatitis A virus. According to recent research published in the European Journal of Clinical Microbiology & Infectious Diseases, "An...

Findings from Al-Azhar University, Microbiology Department advance knowledge in hepatitis B virus in children.(Report)
April 13, 2009... A report, 'High prevalence of occult hepatitis B in hepatitis C-infected Egyptian children with haematological disorders and malignancies,' is newly published data in Liver International. According to a study from Cairo, Egypt, "This study...

Data from University of Ulsan, Department of Internal Medicine advance knowledge in hepatitis B virus therapy.
April 13, 2009... Investigators publish new data in the report 'Hepatitis B virus with the rtL80V/I mutation is associated with a poor response to adefovir dipivoxil therapy.' "Lamivudine (LAM) resistance is frequently associated with various types of genomic...

Scientists at Toranomon Hospital publish new data on hepatitis B virus therapy.(Report)
April 13, 2009... Researchers detail in 'Efficacy of entecavir treatment for lamivudine-resistant hepatitis B over 3 years: histological improvement or entecavir resistance,' new data in hepatitis B virus. "Long-term lamivudine therapy is required for patients...

Studies from Venetian Institute of Molecular Medicine add new findings in the area of hepatitis C virus.(Report)
April 13, 2009... New research, 'Microsomal triglyceride transfer protein polymorphism (-493G/T) is associated with hepatic steatosis in patients with chronic hepatitis C,' is the subject of a report. According to a study from Padova, Italy, "Hepatic steatosis...

Findings from S. Maylin and co-authors provide new insights into hepatitis C virus therapy.
April 13, 2009... Fresh data on hepatitis C virus are presented in the report 'Sustained virological response is associated with clearance of hepatitis C virus RNA and a decrease in hepatitis C virus antibody.' "Viral eradication in chronic hepatitis C patients...

New hepatitis C virus therapy findings from Hiroshima University described.(Clinical report)
April 13, 2009... A report, 'Dose comparison study of pegylated interferon-alpha-2b plus ribavirin in naïve Japanese patients with hepatitis C virus genotype 2: a randomized clinical trial,' is newly published data in Journal of Gastroenterology and...

Reports outline hepatitis C virus therapy study findings from S.R. Kim and colleagues.(Report)
April 13, 2009... Research findings, 'Pegylated interferon plus ribavirin combination therapy for chronic hepatitis C with high viral load of serum hepatitis C virus RNA, genotype 1b, discontinued on attaining sustained virological response at week 16 after...

Research in the area of hepatocellular cancer epidemiology reported from University of New South Wales.
April 13, 2009... New investigation results, 'Predictors and survival in hepatitis B-related hepatocellular carcinoma in New South Wales, Australia,' are detailed in a study published in Journal of Gastroenterology and Hepatology. "Incidence and mortality of...

Investigators at Yonsei University, Department of Surgery publish new data on hepatocellular cancer risk factors.
April 13, 2009... Fresh data on hepatocellular cancer are presented in the report 'The preoperative positivity for serum hepatitis B e antigen did not affect overall survival after curative resection of hepatitis B virus-related hepatocellular carcinoma.'...

Researchers from University of Hong Kong, Department of Medicine detail findings in hepatocellular cancer risk factors.
April 13, 2009... A new study, 'Hepatocellular carcinoma in the Asia pacific region,' is now available. According to a study from Hong Kong, People's Republic of China, "Primary liver cancer, particularly hepatocellular carcinoma (HCC) remains a significant...

Reports on hepatocellular cancer therapy findings from Cairo University, National Cancer Institute provide new insights.(Report)
April 13, 2009... Research findings, 'Expression of pro- and anti-inflammatory cytokines in relation to apoptotic genes in Egyptian liver disease patients associated with HCV-genotype-4,' are discussed in a new report. According to recent research from Cairo,...

New findings in liver cancer in women described from Fudan University, Department of Epidemiology.(Report)
April 13, 2009... Current study results from the report, 'Sex-modified effect of hepatitis B virus infection on mortality from primary liver cancer,' have been published. "Sex and hepatitis B virus (HBV) infection are both important risk factors for primary...

Researchers from University of Barcelona detail new studies and findings in the area of monoclonal antibodies.
April 13, 2009... A new study, 'Risk factors for opportunistic infections in infliximab-treated patients: the importance of screening in prevention,' is now available. "We sought to determine factors associated with opportunistic infections (OI) in...